^
+ Follow AKER HOSPITAL Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 147969
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.


[DatePublished] => 2002-01-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [1] => Array ( [ArticleID] => 147159 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2002-01-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [2] => Array ( [ArticleID] => 146350 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2002-01-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [3] => Array ( [ArticleID] => 145600 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2002-01-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [4] => Array ( [ArticleID] => 145283 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2001-12-29 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
AKER HOSPITAL
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 147969
                    [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers
                    [Summary] => A recent report shows that diabetic patients taking  cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD).  The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.


[DatePublished] => 2002-01-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [1] => Array ( [ArticleID] => 147159 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2002-01-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [2] => Array ( [ArticleID] => 146350 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2002-01-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [3] => Array ( [ArticleID] => 145600 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2002-01-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) [4] => Array ( [ArticleID] => 145283 [Title] => Cholesterol therapy lowers healthcare costs among diabetic sufferers [Summary] => A recent report shows that diabetic patients taking cholesterol controlling drug significantly reduced the length and cost of hospitalization due to cardiovascular disease (CVD). The analysis from the landmark Scandinavian Simvastatin Survival Study (4S) is published in Diabetes Care.
[DatePublished] => 2001-12-29 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1222905 [AuthorName] => Chat Alejandro [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with